RE: FDA Public Hearing on “Using Innovative Technologies and Other Conditions of Safe Use to Expand which Drug Products can be Considered Nonprescription” [Docket No. FDA-2012-N[removed]Statement by Kirsten Moore, Pres

First Page		Document Content
Date: 2012-04-05 16:43:06 Pharmaceutical sciences Emergency contraception Contraception Unintended pregnancy Birth control Over-the-counter drug Cervical cap Levonorgestrel Food and Drug Administration Hormonal contraception Medicine Pharmacology		RE: FDA Public Hearing on “Using Innovative Technologies and Other Conditions of Safe Use to Expand which Drug Products can be Considered Nonprescription” [Docket No. FDA-2012-N[removed]Statement by Kirsten Moore, Pres Add to Reading List Source URL: www.rhtp.org Download Document from Source Website File Size: 160,33 KB Share Document on Facebook

	EMERGENCY CONTRACEPTION History and Access Every woman deserves every chance to prevent an unintended pregnancy. Emergency contraception (EC) provides women with a second chance at DocID: 1tBfR - View Document
	Male reproductive control of women who have experienced intimate partner violence in the United States a Ann M. Moore a, Lori Frohwirth a, Elizabeth Miller b DocID: 1rmAG - View Document
	Microsoft Word - darroch-singh-lancetdocx DocID: 1rgav - View Document
	Afghanistan* Bangladesh* Benin* FP2020 COMMITMENT TO ACTION: MEASUREMENT ANNEX 2015 DocID: 1rafx - View Document
	Afghanistan* Bangladesh* Benin* Bhutan* FP2020 DocID: 1r6pC - View Document